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Abstract
Background: HIV-1 Nef protein contributes to pathogenesis via multiple functions that include enhancement of
viral replication and infectivity, alteration of intracellular trafficking, and modulation of cellular signaling pathways.
Nef stimulates formation of tunneling nanotubes and virological synapses, and is transferred to bystander cells via
these intercellular contacts and secreted microvesicles. Nef associates with and activates Pak2, a kinase that
regulates T-cell signaling and actin cytoskeleton dynamics, but how Nef promotes nanotube formation is unknown.
Results: To identify Nef binding partners involved in Pak2-association dependent Nef functions, we employed
tandem mass spectrometry analysis of Nef immunocomplexes from Jurkat cells expressing wild-type Nef or Nef
mutants defective for the ability to associate with Pak2 (F85L, F89H, H191F and A72P, A75P in NL4-3). We report that
wild-type, but not mutant Nef, was associated with 5 components of the exocyst complex (EXOC1, EXOC2, EXOC3,
EXOC4, and EXOC6), an octameric complex that tethers vesicles at the plasma membrane, regulates polarized
exocytosis, and recruits membranes and proteins required for nanotube formation. Additionally, Pak2 kinase was
associated exclusively with wild-type Nef. Association of EXOC1, EXOC2, EXOC3, and EXOC4 with wild-type, but not
mutant Nef, was verified by co-immunoprecipitation assays in Jurkat cells. Furthermore, shRNA-mediated depletion of
EXOC2 in Jurkat cells abrogated Nef-mediated enhancement of nanotube formation. Using bioinformatic tools, we
visualized protein interaction networks that reveal functional linkages between Nef, the exocyst complex, and the
cellular endocytic and exocytic trafficking machinery.
Conclusions: Exocyst complex proteins are likely a key effector of Nef-mediated enhancement of nanotube
formation, and possibly microvesicle secretion. Linkages revealed between Nef and the exocyst complex suggest a
new paradigm of exocyst involvement in polarized targeting for intercellular transfer of viral proteins and viruses.
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Background
The Nef protein of human and simian immunodeficiency
viruses plays an important role in disease pathogenesis and
progression to AIDS [1-5]. HIV-1 Nef is a 27 kDa phospho-
protein that is membrane-associated via N-terminal myris-
toylation. Diverse functions of Nef include downregulation
of CD4 and MHC-I [4], enhancement of viral replication
and infectivity [1], modulation of T-cell signaling [6-8],
proliferation of multivesicular bodies (MVBs) [4,9-11], and
induction of nanotube formation [12,13].
Nef has been linked to intracellular trafficking via inter-
actions with the endocytic and exocytic host cell machin-
ery [4]. Nef mediates downregulation of CD4 and MHC-I
via well-characterized mechanisms. Nef downregulates
CD4 by bridging between CD4 and the AP-1/AP-2 and/
or AP-3 adapter proteins of clathrin-coated pits, acceler-
ating CD4 endocytosis; Nef also redirects endosomes to
MVBs prior to lysosomal degradation of CD4 [14-18].
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venting superinfection and reducing interference with en-
velope glycoprotein functions. Nef disrupts constitutive
recycling of MHC-I by interacting with PACS-1 and
diverting MHC-I from recycling endosomes to the trans
Golgi network [19,20], which allows infected cells to
evade cytotoxic T-cell surveillance. Fusion of MVBs with
the plasma membrane liberates vesicles, known as exo-
somes, into the extracellular space [21]. Secreted forms of
Nef are associated with exosomes and/or exosome-like
microvesicles, which can enhance activation or apoptosis
of bystander cells, suggesting a potential role in patho-
genesis [22-27].
Nef mediates enhancement of T-cell activation via un-
known mechanisms that involve activation of Pak2
(p21-activated kinase 2) in a multiprotein Nef-Pak2 com-
plex [28-33]. Components of the ~1 MDa Nef-Pak2 mul-
tiprotein complex include Nef, Pak2, Vav, Cdc42,
possibly β-PIX, PI-3-kinase, and other unknown proteins
[31,34-37]. The Src-family kinases (SFKs) Lck and Fyn
play a proximal role in T-cell activation, as they are the
first kinases recruited to the TCR upon antigen binding
[1]. Nef has been shown to interact with the SH3
domains of these SFKs, potentially implicating them in
Nef-mediated enhancement of T-cell activation [1,38,39].
Pak2 activation is required for IL-2 secretion and NFAT
signaling in activated T-cells, and Nef-mediated en-
hancement of cellular activation and viral replication in
primary T-cells [33,40]. Pak2 regulates actin cytoskeleton
dynamics to mediate several functions, including
localization of T-cell signaling microclusters (comprised
of TCR-CD3 complexes, ZAP-70 and SFKs, and adaptors
such as LAT), which in turn influences formation of the
immunological synapse [41-43]. Because activated T-cells
upregulate exosome secretion [44], it is unclear whether
enhanced secretion of exosomes in the presence of Nef
is a direct result of Nef’s association with these microve-
sicles or an indirect consequence of Nef-mediated en-
hancement of T-cell activation.
Nef influences immunological synapse formation; how-
ever, studies reached different conclusions regarding
whether or not Nef inhibits this process. Studies in Jur-
kat cells indicated that HIV-1 Nef impairs formation of
immunological synapses by inhibiting recycling of endo-
cytosed TCR-CD3 complexes and Src family kinases to
the plasma membrane and via mislocalization of N-
Wasp [41,45,46]. However, inhibitory effects of HIV-1
Nef on immunological synapse formation were not
observed in other studies [6,47]. While Nefs from most
non-human primate immunodeficiency viruses inhibit
immunological synapse formation by downregulating
CD28 and TCR-CD3 complexes, SIVcpz and HIV-1 Nefs
do not exhibit this effect [47]. Furthermore, without
altering the quantity or assembly rate of immunological
synapses, HIV-1 Nef expression more than doubled the
number of Jurkat E6-1 cells activated by TCR stimula-
tion, possibly due to rapid recruitment of Nef in lipid
rafts to the immunological synapse [6]. Possible explana-
tions for divergent conclusions regarding effects of HIV-
1 Nef on immunological synapse formation include dif-
ferences in Nef expression levels, the time point at which
immunological synapse formation was analyzed, and Nef
alleles or cell-type studied.
In addition to its effects on formation of immunological
synapses, Nef has been shown to stimulate formation of
other types of intercellular contacts, including virological
synapses and tunneling nanotubes [12,42]. Actin- and
microtubule-dependent clustering of adhesion molecules
and membrane microdomains at virological synapses leads
to formation of short-range tubes through which Gag, Env,
and HIV-1 can traffic between cells by hijacking cellular
transport mechanisms [42]. Nef is required for efficient
HIV replication in co-cultures of dendritic cells and T-
cells [48], which is mediated by virological synapses [42]
and other modes of intercellular transfer [49]. In contrast
to virological synapses, tunneling nanotubes are longer-
range narrow intercellular conduits that form independ-
ent of receptor contacts [42,50]. HIV-1 transfer between
CD4+ T-cells and Nef transfer from infected macro-
phages to B-cells via nanotubes have been reported
[13,51]. Nanotube formation between macrophages and
B-cells is Nef-dependent, and has been proposed to sup-
press NF-κB-induced class-switch recombination by
transferring Nef to B-cells [10,13].
Polarized transfer of Nef between multiple cell-types of
the immune system suggests that Nef exploits host cell
trafficking machinery to maximize its spread. Here, we
report that Nef associates with 5 of the 8 components of
the exocyst complex, an octameric protein complex that
targets vesicles to the plasma membrane, regulates polar-
ized exocytosis, and recruits membranes and proteins
required for nanotube formation. Furthermore, shRNA-
mediated depletion of EXOC2, an exocyst complex sub-
unit, abolishes Nef-mediated enhancement of nanotube
formation. Association of Nef with the exocyst complex
likely plays a role in several proposed functions of Nef,
including Nef-mediated enhancement of microvesicle se-
cretion and nanotube formation, thereby contributing to
cell-cell spread of viral infection and chronic immune ac-
tivation during AIDS pathogenesis.
Results
Identification of cellular proteins associated with
wild-type Nef but not mutant Nefs defective for Pak2
association
To better understand interactions of Nef with the cel-
lular trafficking machinery, we performed mass spec-
trometry analysis of Nef-associated proteins using
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ation with the Pak2-activating complex. Pak2 regulates
cytoskeletal rearrangements and interacts with several
proteins that control cell motility, membrane ruffles,
and filipodia, including Rac1, Cdc42, and β-PIX [52].
Therefore, we used the wild-type 5C Nef, a primary
Nef previously characterized as a strong activator of
Pak2, and two well-characterized 5C-mutants that
have wild-type abilities to downregulate CD4 but are
defective for the ability to associate with and activate
Pak2: 5C-7 (F85L, F89H, H191F in NL4-3) and 5C-
AxxA (A72P, A75P) [53]. 5C-7 Nef is fully functional
for MHC-I downregulation [53], while 5C-AxxA is de-
fective for this function. Disrupting the SH3-binding
PxxP motif at Nef residues 72 to 75 also abrogates
SH3-dependent interactions of Nef with SFKs and
Vav. Thus, 5C-7 and 5C-AxxA allow investigation of
Nef-dependent effects on protein trafficking mediated
via Pak2 activation and/or SH3 binding.
First, we constructed pHAGE lentiviral vectors en-
coding Nef-IRES-ZsGreen under the control of an
EF1-α promoter, to express Nef in the absence of
other viral proteins and allow identification and sort-
ing of Nef-expressing cells. Western blotting con-
firmed that Jurkat E6-1 cells transduced with these
vectors express similar levels of HA-tagged wild-type
or mutant Nefs after gating on cell populations with
matched mean ZsGreen fluorescence and FACS sort-
ing (Figure 1A). Relative to the wild-type and refer-
ence Nefs 5C and NL4-3, which increased the
percentage of CD25-expressing cells by ~2-fold, the
5C-7 and 5C-AxxA Nef mutants exhibited a modest
but reproducible reduction in Nef-mediated enhance-
ment of Jurkat cell activation, as indicated by the per-
centage of pHAGE-transduced cells that upregulate
CD25 following treatment with a sub-threshold stimu-
lus for T-cell activation (1 μg/mL PHA-P; Figure 1B
lower panel and Figure 1C right column). Due to a
bystander effect (i.e., paracrine activation of ZsGreen-
negative Nef-minus cells, possibly mediated by IL-2
and/or Nef secreted from co-cultured Nef-IRES-
ZsGreen-expressing cells), some CD25 upregulation
was also observed in the Nef-minus (ZsGreen-nega-
tive) samples (Figure 1B, left). The lower levels of
CD25 expression in cells bearing 5C-7 and 5C-AxxA
Nefs are consistent with the requirement for Pak2 in
Nef-mediated enhancement of T-cell activation [33],
and decreased ability of these mutant Nefs to activate
Pak2 demonstrated by Agopian et al.[ 5 3 ] .A l t h o u g h
the ~2-fold increase in the percentage of cells expres-
sing CD25 (Figure 1B, vector-transduced Nef- vs. 5C-
transduced Nef+) is a modest effect, these results are
consistent with prior studies of Nef-mediated en-
hancement of Jurkat cell activation [7,33,54] and may
reflect high background activation in these immorta-
lized cells. We also tested additional T-cell activation
markers, CD69 and HLA-DR, in this assay system.
However, CD69 expression was similarly high
(98.7±1.0% with Nef versus 95.2±0.6% without Nef,
SEM, data not shown), and HLA-DR expression
remained low irrespective of Nef expression in
pHAGE-transduced Jurkat cells (8.8±0.1% versus
7.1±0.1%, SEM, data not shown). Therefore, CD25
was used as the readout for Nef-mediated enhance-
ment of T-cell activation based on the increased per-
centage of CD25-positive cells and increase in mean
fluorescence intensity (MFI) (Figure 1B and C).
To identify cellular proteins that associate with wild-type
Nef but not mutant Nefs defective for Pak2 association, we
performed tandem mass spectrometry analysis of Nef-asso-
ciated proteins following immunoprecipitation of Nef from
unsorted cells (53–67% ZsGreen-positive) transduced with
pHAGE-EF1α-IRES-ZsGreen encoding HA-tagged 5C, 5C-
7, or 5C-AxxA, or from sorted populations of Jurkat cells
(100% ZsGreen-positive) isolated via high-speed FACS after
gating on cells with matched mean ZsGreen fluorescence.
Immunoblotting an aliquot of the input lysate utilized for
co-immunoprecipitation and mass spectrometry indicated
that components of the Nef-Pak2 multiprotein complex
were expressed at comparable levels in the sorted and un-
sorted samples (Figure 2, Lanes 1–4a n d5 –7). Jurkat cells
expressing the empty vector pHAGE-EF1α-IRES-ZsGreen
were included as a negative control. Nef immunocomplexes
were eluted with HA peptide, trichloroacetic acid-precipi-
tated, trypsinized, purified, and analyzed via LC-MS/MS.
Mass spectrometry analysis identified peptides from ~65 to
135 proteins in each of the 7 samples (Additional file 1:
Table S1). Approximately 50 of these proteins were detected
in all samples, including empty vector and mutant Nef sam-
ples (Additional file 1: Table S1 and Additional file 2: Table
S2). Consistent with their prior detection as Nef-interacting
proteins [29], peptides mapping to DOCK2 and ELMO1
were identified at high abundance (57 to 91 and 9 to 17
peptides per sample, respectively), and received high scores
from CompPASS (Comparative Proteomics Software Suite
[55]) analysis (Z=10.1 for each, and D
N=33.72and9.21for
DOCK2 and ELMO, respectively) (Additional file 3: Figure
S1, Additional file 1: Table S1 and Additional file 2: Table
S2). The normalized D-score, D
N, provides a measure of
the uniqueness and reproducibility of an interaction, and
the abundance of peptides detected from a given interactor
[56]. However, DOCK2 and ELMO1 were detected in all
samples, irrespective of whether or not the sample con-
tained Nef, and thus could not be considered Nef-interact-
ing proteins. Filtering the mass spectrometry results to
omit proteins that were detected in mutant and empty-
vector samples yielded 10 proteins specifically associated
with wild-type Nef (Table 1).
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Proteins detected via LC-MS/MS analysis of wild-type 5C
Nef-HA immunocomplexes but absent from background
or mutant control samples are shown in Table 1; upper
and lower panels describe individual samples and com-
bined data, respectively. Pak2 was identified in wild-type
Nef, but not mutant Nef or empty vector samples (Table 1
a n dA d d i t i o n a lf i l e1 :T a b l eS 1a n dA d d i t i o n a lf i l e2 :T a b l e
S2), consistent with prior studies that identified Pak2 as a
Nef-associated protein and the 5C-7 and 5C-AxxA
mutants as being defective for association with Pak2 [53].
EXOC1, EXOC2, EXOC3, and EXOC4, 4 of the 8 proteins
that comprise the exocyst complex [58,59], were identified
in 2 independent wild-type Nef immunoprecipitation sam-
ples, and in none of the 5 control samples (Table 1 and
Additional file 1: Table S1 and Additional file 2: Table S2).
In addition, EXOC6 was detected in the sorted 5C Nef
sample (Table 1). CompPASS comparative proteomic ana-
lysis software suite [55] indicated that Nef-association of
EXOC1, EXOC2, EXOC3, EXOC4, EXOC6 and Pak2 is
statistically significant according to Z-scores and/or nor-
malized D-scores (D
N)( T a b l e1 ,A d d i t i o n a lf i l e3 :F i g u r e
S1, Additional file 1: Table S1 and Additional file 2: Table
S2). Variation in whether individual proteins were detected
Figure 1 Nef mutants defective for association with Pak2 are also defective for the ability to enhance T-cell activation upon PHA
stimulation. A) Jurkat E6-1 cell lysates were harvested at 48 hpi following transduction with VSV-G pseudotyped pHAGE-Nef-HA-IRES-ZsGreen
vector virions encoding wild-type (Lane 2) or mutant Nefs (Lanes 3 and 4), or empty vector (Lane 1), separated by SDS-MOPS-PAGE, and
immunoblotted to detect HA-tagged Nef and endogenous Pak2. Lane 4 is a non-contiguous lane from the same gel as Lanes 1–3. For clarity,
brightness and contrast of the Nef panels were increased by 2%. B) CD25 expression on Jurkat E6-1 cells transduced with VSV-G pseudotyped
pHAGE-EF1α-IRES-ZsGreen vector encoding wild-type (NL4-3 or 5C) or mutant (5C-7, 5C-AxxA) Nef or empty vector was analyzed at 48 h
post-transduction, with (lower panel) or without (upper panel) 1 μg/mL PHA-P stimulation for 24 h prior to FACS analysis. ZsGreen expression is a
reporter for pHAGE transduction and Nef expression, except in the case of vector samples, which lack Nef. For each sample, the Nef allele
encoded in the pHAGE-IRES-ZsGreen vector virions is indicated (see legend). Bars graphed on the left and right of each panel represent the
ZsGreen-negative and ZsGreen-positive subsets of cells from each transduction. C) FACS plots and gating strategy for panel B are shown. The gate
“P2” demarcates populations of matched ZsGreen fluorescence for which percentages of CD25-positive cells are reported in panel B.
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fluctuation in peptides contacting the detector during
mass spectrometric analysis. Therefore, detection of
EXOC1, EXOC2, EXOC3, and EXOC4 in two independ-
ent mass spectrometry samples (i.e., immunocomplexes
from sorted and unsorted cells) raises confidence in Nef-
exocyst complex association. Thus, 5 proteins of the exo-
cyst complex were associated with wild-type Nef, but not
mutant Nefs or empty vector negative controls.
In addition to Pak2 kinase and the 5 exocyst complex
components, 4 other proteins were detected exclusively
in immunocomplexes containing wild-type Nef: p105
subunit of NF-κB, variable region of myosin-reactive Igκ
chain, microfibrilliar protein 2, and 40S ribosomal sub-
unit (Table 1). Some studies suggest involvement of Nef
in HIV-mediated enhancement of NF-κB induction [60],
while others did not observe NF-κB activation when Nef
was expressed in the absence of other HIV proteins
[61,62]. Therefore, detection of NF-κB in 5C Nef immu-
nocomplexes from sorted cells may reflect cytoplasmic
retention of NF-κB [13], rather than specific association
of NF-κB with Nef. The 40S ribosomal subunit was likely
detected due to its high abundance in cells; however,
exocyst-mediated effects on protein synthesis and trans-
lation have been reported [63]. Peptides matched to the
variable region of myosin-reactive Igκ chain and microfi-
brilliar protein 2 were identified with lower confidence,
as these were single-peptide hits corresponding to pro-
tein fragments in a subdivision of UniProt that is not
reviewed (UniProt/TrEMBL), as compared to UniProt/
SwissProt, which is manually curated [57]. The finding
that Pak2 was identified only in unsorted cells, while
NF-κB was detectable only in sorted cells, may reflect
stochastic fluctuation in peptides contacting the
detector.
To verify the association of Nef with EXOC1,
EXOC2, EXOC3, and EXOC4 revealed by mass spec-
trometry analysis, we performed a co-immunoprecipi-
tation assay with 5C, 5C-7, and 5C-AxxA Nefs from
pHAGE-transduced Jurkat cells and analyzed the co-
immunoprecipitated proteins via Western blotting
(Figure 3). The results confirmed that endogenous
EXOC1-4 associate with 5C Nef in Jurkat cell lysates
(Figure 3, Lane 2). In contrast, association with the
mutant Nefs 5C-7 and 5C-AxxA was undetectable for
EXOC1, EXOC3, and EXOC4, and barely detectable
for EXOC2, compared to the control sample lacking
Nef (Figure 3, Lanes 3 and 4 versus Lane 1). Pak2
and β-tubulin were immunoblotted as positive and
negative controls for Nef co-immunoprecipitation, re-
spectively. These co-immunoprecipitation results pro-
vide validation for the mass spectrometry analysis of
Nef-associated proteins, confirming that Nef associates
with EXOC1-4.
Network analysis of Nef-exocyst interactome identifies
functional linkages
To visualize functional interactions between Nef and the
exocyst complex, we generated protein-association net-
works using bioinformatic tools. Three well-character-
ized Nef interactors (Pak2, Vav, and AP2M1, the μ-
subunit of adapter protein 2), regulators and effectors of
the exocyst complex (RalA, Ral-binding protein, Aurora-
A, phosphatidylinositol-4-phosphate 5-kinase type I γ,
Cdc42, PIX, and Arf6), and exocyst complex components
detected via mass spectrometry (EXOC1, EXOC2,
EXOC3, EXOC4, and EXOC6) were selected as input
molecules to generate a network (Figure 4A) using In-
genuity Pathway Analysis (IPA) [Ingenuity
W Systems].
IPA predicted that all of the input molecules are con-
nected in a single, high-scoring network that links cell
signaling, lipid metabolism, and endosomal trafficking, in
particular endocytosis and endocytic recycling (Fig-
ure 4A). RalA, the adapter protein 2 complex, Pak2, and
Vav/Cdc42 represent major hubs of functional inter-
action between Nef and the exocyst complex (gold oval,
Figure 4A). To visualize interactions by which the Nef-
exocyst interactome interfaces with regulators of Pak2
and the cytoskeleton, we created an additional network
(Figure 4B) using STRING, a bioinformatic tool that
maps protein-protein associations based on evidence
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Figure 2 Nef-Pak2 complex proteins are expressed at
comparable levels in pHAGE-Nef transduced Jurkat cells utilized
for mass spectrometry. Proteins immunoblotted in 1% of the input
lysates utilized for LC-MS/MS analysis are shown. Jurkat E6-1 cell
lysates were harvested 48 h after transduction with VSV-G
pseudotyped pHAGE-Nef-HA-IRES-ZsGreen vector virions encoding
wild-type wild-type (Lane 2 and 6) or mutant Nefs (Lanes 3, 4, and
7), or empty vector (Lanes 1 and 5). Lysates analyzed in Lanes 5–7
were derived from unsorted cells, while lysates in Lanes 1–4 were
from cells sorted to obtain populations with matched ZsGreen
fluorescence. β-tubulin is included as a loading control.
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omics, experimental data, pathway databases, natural
language processing (e.g., textmining for co-occurrence
of protein names in PubMed abstracts), and homology
[64]. The STRING network (Figure 4B and Additional
file 4: Table S3) visualized protein-protein association
relationships that link Nef and the exocyst complex to
regulators of endocytosis, cytoskeletal remodelling, lipid
metabolism, and membrane trafficking, and identified
Cdc42, RalA, and Arf6 as key nodes of functional inter-
action between Nef and the exocyst complex. These find-
ings are consistent with the network predicted by IPA
(Figure 4A), prior reports suggesting that Nef-mediated
regulation of Arf6 plays a role in modulating clathrin-
dependent endocytosis [3,19],a n dk n o w ni n t e r a c t i o n so f
Arf6 with the exocyst complex that mediate membrane re-
cruitment to polarized plasma membrane sites [65].
EXOC2 depletion abrogates Nef-mediated enhancement
of nanotube formation
The exocyst complex mediates intercellular nanotube
formation [66]. Given that Nef has been reported to en-
hance nanotube formation [13], we sought to determine
whether the exocyst complex is an effector in Nef-
mediated enhancement of nanotube formation. To ad-
dress this question, we performed pLKO.1-shRNA
knockdowns targeting EXOC2 in Jurkat cells, trans-
duced these cells with pHAGE-Nef-IRES-ZsGreen or
empty vector, and assayed for nanotube formation using
Table 1 Cellular proteins detected exclusively in wild-type Nef immunocomplexes
Accession Gene Protein Description Unique #
peptides
FACS-sorted 5C Nef
Q9NV70 EXOC1 EXOC1 Exocyst complex component 1, isoform 1 3
Q96KP1 EXOC2 EXOC2 Exocyst complex component 2 3
O60645 EXOC3 EXOC3 Exocyst complex component 3, isoform 1 3
Q96A65 EXOC4 EXOC4 Exocyst complex component 4 6
Q8TAG9 EXOC6 EXOC6 Exocyst complex component 6 1
Q9UL85
a Myosin-reactive Igκ chain variable region (fragment) 1
P19838 NFKB1 NFKB1 Nuclear factor NF-κB p105 subunit, isoform 2 1
Unsorted 5C Nef
Q9NV70 EXOC1 EXOC1 Exocyst complex component 1, isoform 1 3
Q96KP1 EXOC2 EXOC2 Exocyst complex component 2 3
O60645 EXOC3 EXOC3 Exocyst complex component 3, isoform 1 2
Q96A65 EXOC4 EXOC4 Exocyst complex component 4 4
Q9NP29
a Microfibrillar protein 2 (fragment) 1
Q13177 PAK2 Pak2 PAK2 Serine/threonine-protein kinase 3
P60866 RPS20 RS20 40S ribosomal protein S20 1
Gene or Accession D
N-score
b Z-score
b Description Total #
peptides
Unique #
peptides
FACS-sorted and unsorted 5C Nef combined
EXOC1 7.14 10.09 Exocyst complex component 1, isoform 1 6 5
EXOC2 7.14 10.09 Exocyst complex component 2 6 5
EXOC3 5.83 10.09 Exocyst complex component 3, isoform 1 4 4
EXOC4 9.21 10.10 Exocyst complex component 4 10 6
EXOC6 0.41 10.05 Exocyst complex component 6 1 1
NFKB1 0.05 −0.59 Nuclear factor NF-κB p105 subunit, isoform 2 1 1
PAK2 0.70 10.09 PAK2 Serine/threonine-protein kinase 3 3
Q9NP29
a 0.41 10.05 Microfibrillar protein 2 (fragment) 1 1
Q9UL85
a 0.41 10.05 Myosin-reactive Igκ chain variable region (fragment) 1 1
RPS20 0.04 −1.51 40S ribosomal protein S20 1 1
a) Unreviewed entries from UniProtKB/TrEMBL; all other accessions from Swiss-Prot/UniProtKB [57]. b) Statistical scores obtained via CompPASS analysis.
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actin and the Nef reporter ZsGreen (Figure 5). Treat-
ment of Jurkat cells with an shRNA targeting EXOC2
decreased EXOC2 expression by at least 2-fold, com-
pared to treatment with a control shRNA that does not
target any human transcripts (Figure 5A, “EXOC2” ver-
sus “Control”). We observed percentages of nanotube-
forming cells comparable to those reported by others for
Jurkat E6-1 cells [51,67]. In pHAGE-transduced popula-
tions expressing comparable levels of Nef (Figure 5A),
greater than 8% of ZsGreen-positive, Nef-expressing cells
formed nanotubes and nanotube-like structures after treat-
ment with a control shRNA, whereas the corresponding
value for EXOC2 knockdown cells was<0.4% (Figure 5B).
The control shRNA cells expressing Nef exhibited morpho-
logical changes consistent with cytoskeletal rearrangements
and cell polarization (Figure 5D): these cells formed at least
3-fold more nanotubes and nanotube-like structures com-
pared to corresponding cells lacking Nef. Moreover, in Nef-
expressing cells, nanotubes were more robust and occurred
more frequently, in some cases with multiple connections
originating from a single cell (approximately 5% of nano-
tube-forming cells) (Figure 5B and 5D, and Additional file
5: Figure S2). In contrast, Jurkat cells expressing an shRNA
targeting EXOC2 formed few, if any, nanotubes, irrespective
of whether or not Nef was expressed (Figure 5E and 5F).
Thus, depletion of EXOC2 abrogated Nef-mediated en-
hancement of nanotube formation (Figure 5B; p<.05,
Mann–Whitney U). These findings suggest that exocyst
complex function is required for Nef-mediated enhance-
ment of nanotube formation.
Discussion
Our findings demonstrate a novel association of Nef with
the host cell exocytic machinery that has implications for
understanding mechanisms involved in intercellular
transfer of Nef and other HIV-1 proteins. We identified
EXOC1, EXOC2, EXOC3, EXOC4, and EXOC6 as Nef-
associated proteins via mass spectrometry analysis of Nef
immunocomplexes isolated from Jurkat cells, and
showed this association was disrupted by mutations that
abrogate the ability of Nef to associate with and activate
Pak2 kinase. Furthermore, association of wild-type, but
not mutant Nef, with EXOC1, EXOC2, EXOC3, and
EXOC4 was verified by co-immunopreciptation assays in
Jurkat cells. Importantly, shRNA-mediated depletion of
EXOC2 abrogated Nef-mediated enhancement of nano-
tube formation in Jurkat cells. Together, these results
suggest that the exocyst complex is likely to be a key ef-
fector mediating Nef’s ability to promote nanotube for-
mation, and may mediate some of its other functions as
well (e.g. microvesicle secretion). DOCK2 and ELMO1
were previously reported as Nef-interacting proteins
[29]; however, we detected DOCK2 and ELMO1 in all of
the mass spectrometry samples, including empty vector
control samples, and the number of peptides detected
did not differ significantly in the presence or absence of
Nef, suggesting these proteins are not specifically asso-
ciated with Nef (Additional file 1: Table S1 and Add-
itional file 2: Table S2).
Our finding that Nef associates with EXOC1-4 and
EXOC6 in Jurkat cells is consistent with a recent publi-
cation from the Krogan lab, which reported that Nef
associates with EXOC4 based on affinity tagging and
mass spectrometry analysis using a different Nef allele
(HxB2 Nef fused to a 2X Strep and 3X FLAG purifica-
tion tag) expressed in Jurkat cells [17]. In this study,
MiST (mass spectrometry interaction statistics) assigned
this interaction a score of .769, where a threshold of .75
indicates significance [17]. The authors were not able to
reproduce Nef-EXOC4 association by co-immunopreci-
pitation assays in transfected 293T cells, however, raising
the possibility that a cell-type-specific factor(s) may be
required for Nef-EXOC4 association [17].
Nef-mediated enhancement of T-cell activation
requires stimulation via TCR or PMA/PHA (Figure 1B
and 1C). Our proteomic analysis was performed using
Figure 3 Exocyst complex components EXOC1, EXOC2, EXOC3,
and EXOC4 co-immunoprecipitate with wild-type, but not
mutant Nefs, in Jurkat E6-1 cell lysates. Nef-HA
immunocomplexes (right) and input lysates (left) from Jurkat E6-1
cells harvested at 48 h post-transduction with pHAGE virions bearing
wild-type (5C, Lane 2) or mutant Nefs (5C-7, 5C-AxxA; Lanes 3 and 4)
or empty pHAGE-IRES ZsGreen vector (Lane 1) were immunoblotted
to detect endogenous EXOC1, EXOC2, EXOC3, EXOC4, Pak2, and HA-
tagged Nef. β-tubulin is included as a loading control.
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CD25 expression detected little or no expression of T-
cell activation markers (Figure 1B upper panel and 1C).
These observations suggest that the enhanced nanotube
formation and secretion of microvesicles from Nef-
expressing cells reported in prior studies [13,22-24] may
be due to a direct effect of Nef on the exocytic machin-
ery, rather than an indirect effect of Nef-mediated en-
hancement of T-cell activation. Microarray data from
Jurkat cells expressing SIV Nef indicated that exocyst
complex components were upregulated only 1.5 to 2-fold
[68], and gene expression profiles of CD4+ T-cells from
HIV-infected patients compared to uninfected individuals
showed only minor effects on levels of transcripts encod-
ing exocyst complex proteins [69]. Thus, our mass spec-
trometry data is likely to reflect direct or indirect
association of Nef with the exocyst complex, rather than
Nef-induced enhancement at the level of gene expression
or enhancement of T-cell activation.
In light of our finding that Nef associates with exo-
cyst complex subunits, protein interaction network
modelling (Figure 4), EXOC2 shRNA-mediated inhib-
ition of nanotube formation in Nef-expressing cells, and
review of literature, including prior reports that Nef
enhances microvesicle secretion and nanotube forma-
tion [13,23-25], we propose a potential model to unify
these pathways (Figure 6). Our proposed model is based
on established Nef-mediated enhancement of endocyto-
sis and exocytosis, and predicted Nef-mediated en-
hancement of exocyst complex assembly. Nef binding
to adapter protein 2 μ-subunit (AP2M1) enhances
endocytosis and trafficking of Nef to recycling endo-
somes [70]. Upon Nef-mediated activation of Pak2, Pak2
activates Aurora-A [71], which phosphorylates a major exo-
cyst complex assembly regulator, RalA GTPase [72,73].
RalA mediates assembly of exocyst complex components,
enabling polarized docking with membrane-associated
EXOC1 and EXOC7 [58,59,74] on endosomes and/or re-
cycling endosome-derived vesicles. Interaction of Nef with a
protein complex that includes the exocyst complex and
RalA may therefore lead to Nef-mediated formation of
nanotubes. Non-filamentous assembly of actin may lead to
Figure 4 Visualization of protein interaction networks of Nef-interacting proteins and exocyst complex components, regulators, and
effectors. A) IPA network of Nef-interacting proteins and exocyst complex components, regulators, and effectors. Inputting 16 molecules
(depicted as red nodes, described in the text) into Ingenuity Pathways Analysis [Ingenuity
W Systems, www.ingenuity.com] yielded a network of 35
molecules, of which 13 [Calmodulin, Dock1-Pak, ERK1/2, Exocyst, Jnk, NFkB (complex), Phosphatidylinositol 4,5 kinase, PI3K (complex), PIP4K2C, Pkc
(s) Pld, Ras, and TCR] were omitted for clarity. Components of the exocyst complex are encircled by a gold oval. Manually-curated edges are
shown in dark blue, and dashed arrows denote activation via indirect association. IPA assigned this network a score of 42, which is based on the
hypergeometric distribution and is the -log(right-tailed Fisher’s exact test result). The score implies a 1 in 10
42 chance of obtaining a network
containing at least the same number of network eligible molecules by chance when randomly picking 16 molecules that are present in networks
from the Ingenuity Knowledge Base. B) STRING network of Nef-interacting proteins and exocyst complex components, regulators, and effectors.
Inputting 19 molecules (16 molecules input into IPA, plus EXOC5, EXOC7, and EXOC8; depicted as spheres) into STRING yielded a network
visualizing linkages between Nef, the exocyst complex, and regulators of the actin cytoskeleton. Components of the exocyst complex are
encircled by a gold oval. Manually-curated edges are shown in dark blue, and dashed arrows denote activation via indirect association. Other
edge colors reflect the evidence channels (see legend) by which protein nodes are related in the STRING database. Scores STRING assigned to
relationships depicted in this network are provided in Additional file 4: Table S3.
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http://www.retrovirology.com/content/9/1/33Figure 5 EXOC2 depletion abrogates Nef-mediated enhancement of nanotube formation. A) Lysates of Jurkat E6-1 cells transduced with
vector virions bearing pLKO.1-shRNA followed by pHAGE-Nef-IRES-ZsGreen encoding 5C (wild-type) or empty pHAGE were harvested 32 h post-
pHAGE transduction and immunoblotted to detect endogenous EXOC2, HA-tagged Nef, and β-tubulin. Samples were treated with an shRNA
targeting EXOC2 (right lane, EXOC2) or a control shRNA that does not target the human transcriptome (left lane, Control). B -F) Jurkat cells
transduced as described above were stimulated with 1 ug/mL PHA-P for 1 h at 24 h post-pHAGE transduction, incubated on fibronectin-coated
coverslips for 5 h, fixed at 30 h post-pHAGE transduction and phalloidin-stained prior to visualization by confocal fluorescence microscopy. B)
Percentages of ZsGreen-positive Jurkat cells that formed nanotubes and nanotube-like structures in populations treated with shEXOC2 (right) or
shControl (left) are shown. Differences betweenNef-expressing samples treated with control versus EXOC2 shRNAs were significant, as were
differences between control shRNA-treated cells with versus without Nef expression (“*” denotes p<0.05, Mann–Whitney U). The percentage of
Nef-expressing cells that formed nanotubes and nanotube-like structures was calculated by manually counting the number of connected cells
and dividing the result by the total number of ZsGreen-positive cells for a given sample. The total numbers of ZsGreen-positive cells counted in
30 fields at 40X magnification are detailed in the Methods. Data represent percentages of ZsGreen-positive cells connected by nanotubes, and are
reported as mean ± SEM. C-F) Selected fields that contain nanotubes (C and D) and representative confocal fluorescence images (E and F) from
the samples quantified in B are shown. Actin-containing nanotubes and nanotube-like structures were visualized via Alexa Fluor 555-conjugated
phalloidin; pHAGE-transduced cells were detected via ZsGreen fluorescence. Scale bars, 5 μm.
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which transfer to bystander cells following plasma mem-
brane rupture. Thus, our findings, together with previous
studies [13,25,66], suggest potential involvement of RalA
and the exocyst complex in Nef-mediated formation of
nanotubes and enhanced release of exosome-like vesicle
clusters.
Interactor(s) that mediate Nef association with exocyst
complex subunits are not yet clear. One possibility is
that Nef may interact directly with a component(s) of
the exocyst complex. In this scenario, Nef might function
as a viral homolog of a cellular exocyst complex regula-
tor downstream of Pak2 activation. Among the exocyst
complex components detected in our mass spectrometry
analysis, the greatest number of peptides were derived
from EXOC4 (Table 1), the same component identified
by Jager et al. as a Nef-interacting protein in their prote-
omic screen [17]. Taken together, these data suggest
EXOC4 represents a potential candidate for an exocyst
complex protein that may bind directly to Nef. Given
predicted protein interaction networks (Figure 4), Nef-
AP2M1 binding is another potential means of Nef-
exocyst complex association. Co-immunoprecipitation of
Nef with Rab11 has been reported [77], raising the al-
ternative possibility that Rab11 might bridge between
Nef and the exocyst complex via its interaction with
EXOC6 [78]. Our co-immunoprecipitation assays were
conducted in lysis buffer containing a concentration of
detergent sufficient to disrupt membranes (1% Triton
X-100); therefore, it seems unlikely that Nef-exocyst
complex association could be attributed to membrane
bridging. Both Nef and the exocyst complex are tar-
geted to lipid rafts [30,54,79,80], and both have been
linked to nanotube formation [13,66]. As such, Nef and
the exocyst complex are likely to co-localize at plasma
membrane sites to mediate nanotube formation. Further
studies are required to determine whether Nef associ-
ation with the exocyst complex is direct or indirect, and
Figure 6 Proposed model of Nef-mediated enhancement of nanotube formation via the exocyst complex. Based on proteomics data and
protein interaction networks shown in Table 1 and Figure 4, a model of Nef-mediated enhancement of nanotube formation and microvesicle
release is shown (described in the text). Briefly, Nef i) traffics to recycling endosomes via enhanced endocytosis, ii) upregulates exocyst complex
assembly via Pak2-stimulated Aurora kinase activation (AURKA) [71] and phosphorylation and relocalization of RalA [73], and iii) budding of
Nef-bearing vesicles from recycling endosomes [75,76] and enhances iv) Nef secretion in microvesicles (see “tether and burst”) [25] and v)
nanotube formation via exocyst complex function, thereby increasing intercellular transfer of Nef. Protein complexes denoted in boxes act at the
indicated steps. The exocyst complex is abbreviated as “E8” and depicted as green octagons.
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other yet unknown protein(s) bridge between Nef and
the exocyst complex. RNAi-mediated knockdown
experiments targeting nodes of the Nef-exocyst interac-
tome network (Figure 4) will help to elucidate the
mechanism(s) by which Nef hijacks exocyst function to
enhance nanotube formation. Additionally, future stud-
ies utilizing Nef mutants to map determinants of Nef-
exocyst association will be important to clarify the func-
tional relationships between Nef-Pak2 and Nef-exocyst
interactions.
Several nodes of our Nef-exocyst interactome (Figure 4)
are in agreement with results of prior proteomic and
RNAi-based studies of HIV interactions with the host
cell (Additional file 6: Figure S3). In their proteomic
study with Jurkat cells, Jager et al. also identified Vav
and the clathrin adapter proteins AP1S1A and AP3S1 as
Nef-interacting proteins [17]. Furthermore, siRNA
screens indicated that AP2M1, PIP5K1C, RAB11A, RalB,
and RalBP1 expression is important for HIV-1 replica-
tion [81,82]. Therefore, in addition to the role of Nef-
mediated enhancement of nanotube formation, it is pos-
sible that interaction of HIV-1 proteins with Nef-exocyst
interactome components (Figure 4 and Additional file 6:
Figure S3) may have broader functional implications for
viral replication. Future studies to examine the effects of
RNAi-mediated knockdown of EXOC2 and other Nef-
exocyst interactome components will be important to
understand the contribution of these interactions to HIV
replication and pathogenesis.
There are striking similarities between mechanisms by
which nanotubes, filopodia, virological synapses, and im-
munological synapses are formed, which include cytoskel-
etal polarization, membrane protrusion, and recruitment of
proteins to discrete membrane domains that serve as foci
for endocytosis and exocytosis [42,66,83-85]. Furthermore,
exocyst complex function is required for formation of filo-
podia and nanotubes [66,85]. Together with our findings
that Nef associates with exocyst components and EXOC2
is required for Nef-mediated enhancement of nanotube for-
mation, these observations provide further support for a
m o d e li nw h i c hf o r m a t i o no fN e f - i n d u c e dn a n o t u b e s[ 1 3 ]
involves Nef-mediated regulation of the exocyst complex.
The relationship of our findings to Nef-mediated
enhancement of viral replication and cellular activa-
tion remains an open question. Cell-to-cell transfer is
an important mode of HIV-1 dissemination within the
host; for CD4+ T-cells, intercellular transfer is 2 to 3
logs more efficient at supporting viral replication than
HIV-1 infection with cell-free inoculum [42,50]. Nef
enhances formation of the virological synapse, which
is structurally similar to intercellular nanotubes [42].
Thus, Nef-mediated regulation of the exocyst complex
m a ya l s op l a yar o l ei ni n t e r c e l l u l a rt r a n s m i s s i o no f
HIV-1 via the virological synapse. Exosomes or micro-
vesicles that contain Nef [24] or proinflammatory
molecules such as cytokines [86] contribute to cell ac-
tivation [25] and activation-induced apoptosis [24]. As
such, Nef may increase chronic immune activation in
part by upregulating exocyst complex function and
microvesicle secretion.
Conclusions
Identification of EXOC1, EXOC2, EXOC3, EXOC4, and
EXOC6 as Nef-interacting host cell factors and our finding
that EXOC2 depletion abrogates Nef-mediated enhance-
ment of nanotube formation provide a new paradigm for
future investigations into Nef-mediated mechanisms
involved in nanotube formation, intercellular transfer of
Nef, cell-to-cell spread of HIV-1, and acceleration of dis-
ease progression. Moreover, this paradigm of exocyst in-
volvement in polarized targeting for intercellular transfer
of viral proteins and virions is likely to be relevant for
other pathogens as well. For example, HTLV and prions
spread from cell to cell via virological synapses and nano-
tubes, respectively [87,88]. Understanding interactions be-
tween viral proteins and exocyst complex components
may therefore lead to the discovery of novel strategies to
inhibit intercellular spread of diverse pathogens.
Availability of supporting data
Supporting data are included within the article and its
additional files.
Methods
Cell culture
Jurkat clone E6-1 cells (ATCC) were maintained in
high-glucose RPMI 1640 medium with 0.3 mg/L L-
Glutamine (GIBCO), supplemented with 10% fetal bo-
vine serum, 1 mM sodium pyruvate, 14 mM glucose,
55 nM β-mercaptoethanol, and penicillin-streptomycin.
HEK293T cells were maintained in DMEM (GIBCO)
supplemented with 10% fetal bovine serum and penicil-
lin-streptomycin.
Lentiviral vector construction and production
pHAGE viral vector stocks were made as follows: Nef
genes were inserted into pHAGE EF1α-IRES-zsGreen,
kindly provided by the Harvard Gene Therapy Initiative
[89], via PCR amplification from pCR3.1 constructs
using the primers 5′AAAAGCGGCCGCCACCATGGG
TGGCAAGTGGTCAAAA3′ and 5′AAGGATCCTCAT
GAAGCGTAATCTGGCAC 3′, which add a NotI site
and a Kozak sequence to the 5′ end of Nef and a BamHI
site to the 3′ end of Nef. GenJet (Signagen) lipid trans-
fection was used to introduce 3 μg of pHAGE vector,
3 μg of the packaging construct pDR89.1 [90], and 0.5 μg
of pVSV-G per 5.5×10
6 293T cells plated 24 h prior in a
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removed and replaced with fresh media at 16 h post-
transfection. Two fractions of vector-containing superna-
tants were harvested from each plate: after an additional
24 h, supernatants were removed, stored at +4°C,
replaced with fresh media, and then pooled with super-
natants collected 24 h hence to generate viral stocks.
pHAGE vector virion stocks were assayed for RT activity
as described previously [91]. pLKO.1 vector virions were
made via the same process, substituting pLKO.1-shRNA-
puro
R constructs (Sigma, Mission shRNA) in lieu of
pHAGE.
Lentiviral vector transduction of Jurkat cells
Twenty million (for immunoprecipitation) or 8×10
6
(for nanotube formation assay) Jurkat E6-1 cells were
pHAGE-transduced with cpm/cell units of RT activity
normalized to yield populations of matched ZsGreen
fluorescence (~0.2 cpm/cell and 0.05 cpm/cell for
pHAGE-Nef-IRES-zsGreen and pHAGE-IRES-zsGreen
vector virions, respectively). At 4 h post-transduction,
cells were washed twice with PBS and incubated in
fresh media overnight (for nanotube formation assay),
or for an additional 44 h (for immunoprecipitation
and mass spectrometry).
Nef immunoprecipitation from Jurkat cell lysates
At 48 h post-transduction, Jurkat E6-1 cells trans-
duced with pHAGE vector virions as described above
were lysed in 1 mL of ice-cold lysis buffer with prote-
ase and phosphatase inhibitors [CLB + PPI: 50 mM
Tris HCl pH 7.5, 150 mM NaCl, 1% Triton, 1 mM
EDTA, 1X Complete EDTA-free protease inhibitor
cocktail (Roche), 1X PhosSTOP phosphatase inhibitor
cocktail (Roche)] and 0.45 μm spin-filtered (Millipore
UFC40HV00). Immunocomplexes were captured with
α-HA-agarose (Santa Cruz, clone F-7) during over-
night incubation with rotation at 4°C, rinsed 5 times
with CLB + PPI and 3 times with 1X PBS, and eluted
in PBS with 250 μg/mL HA peptide (Sigma, #I2149)
and 1X Complete EDTA-free protease inhibitor cock-
tail (Roche) at room temperature.
Mass spectrometry
Jurkat E6-1 cells (20×10
6) were transduced with
pHAGE vector virions and lysed for immunoprecipita-
tion with α-HA-conjugated agarose as described
above.
Nef-HA immunocomplexes were eluted with HA
peptide, trichloroacetic acid-precipitated, trypsinized,
purified, and analyzed via LC-MS/MS on a Velos LTQ
Linear ion trap mass spectrometer at the Harvard
Medical School Taplin Biological Mass Spectrometry
Facility.
Gel electrophoresis and silver staining
Prior to co-immunoprecipitation for mass spectrometry,
1% of the input was resolved via 4–12% Bis-Tris SDS-
PAGE in MOPS buffer (Novex) and silverstained accord-
ing to the manufacturer’s protocol (SilverQuest, Invitro-
gen/Life Technologies).
Immunoblotting
Samples were subjected to SDS-PAGE (4–12% Bis-
Tris in 1X MOPS, Novex) and transferred to PVDF
(0.2 μm, Bio-rad) for immunoblotting. Blots were
blocked with protein-free T20 blocking buffer
(Thermo Scientific), and then probed with α-HA-HRP
(1:500, Roche), mouse α-β-tubulin (1:2000, Sigma-
Aldrich), rabbit α-PAK2 (1:1000, Cell Signaling),
rabbit α-EXOC1 (1:250, Proteintech Group), rabbit α-
EXOC2 (1:250, Proteintech Group), mouse α-EXOC3
( 1 : 2 5 0 ,E n z oL i f eS c i e n c e s ,c l o n e9 H 5 ) ,o rm o u s eα-
EXOC4 (1:1000, Enzo Life Sciences, clone 14G1), and
α-mouse or α-rabbit IgG (both Santa Cruz, 1:5000) in
protein-free T20 blocking buffer. Immunoblots were
washed and visualized via enhanced chemilumines-
cence (Thermo Fisher) and autoradiography (Kodak,
XAR film). Signal intensity for EXOC2 was quanti-
tated using ImageJ software (NIH, v1.45p), and nor-
malized to the β-tubulin loading control.
FACS analysis
Jurkat E6-1 cells (4×10
5) were washed twice with cold
PBS containing 2 mM EDTA (PBS-E) and resuspended
in 200 μl of PBS-E containing 2% FBS and 5 μl of CD25-
PE (BD Pharmingen). Cells and antibody were incubated
at 4°C for 45 min. Cells were washed twice with PBS-E,
resuspended in PBS and analyzed on a BD FACSCanto II
flow cytometer. FACS data was analyzed using BD
FACSDiva software.
Network analysis of the Nef-exocyst interactome
Exocyst complex proteins identified via mass spectrom-
etry analysis of Nef immunocomplexes, known regula-
tors of exocyst complex function, and known Nef-
interacting proteins were input into Ingenuity Pathway
Analysis and STRING to generate network diagrams of
the Nef-exocyst interactome. The IPA bioinformatic ana-
lysis suite maps the identifier for each input molecule to
its corresponding object in Ingenuity’s Knowledge Base,
overlays network eligible molecules onto a global mo-
lecular network developed from information contained
in Ingenuity’s Knowledge Base, and then algorithmically
generates networks of network eligible molecules based
on their connectivity [www.ingenuity.com]. STRING
assigns confidence scores using presence of proteins in
the same Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway as a benchmark to judge authenticity
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dence scores as the joint probability of the probabilities
from the different evidence channels, correcting for the
probability of randomly observing an interaction [64].
Generation of shRNA knockdown cells
Jurkat E6-1 cells were transduced with VSV-G pseudo-
typed pLKO.1-shRNA-UbiC-puro
R vector virions as
described above, and cells expressing shRNAs were
selected with 1 ug/mL puromycin for 8 days beginning
at 48 h post-transduction. Puromycin selection was
removed for 5 days prior to fixation of nanotubes.
pLKO.1 constructs encoding shRNAs against human
EXOC2 (TRCN0000289958, CCGGCGTGGCACATATT
GAAGCATTCTCGAGAATGCTTCAATATGTGCCAC
GTTTTTG) or a non-human control transcript
(SHC-002) were obtained from Sigma (Mission shRNA).
Nanotube formation assay
Jurkat shRNA knockdown cells were generated and
pHAGE-transduced as described above, stimulated with
1 μg/ml PHA-P for 1 h at 24 h post-pHAGE transduction,
washed twice with cold PBS, and resuspended at 2 x 10
6
cells/mL in pre-warmed 50% conditioned media. 22 mm x
22 mm coverslips (Fisher) were ethanol-sterilized, coated
with 10 ug/mL fibronectin (Sigma, #F4759), dried over-
night and washed 5 times with room temperature PBS
and once with media immediately prior to plating 250 ul
of cell suspension per coverslip. After 5 h incubation at
37°C, cells were fixed and stained as follows: 0.1%
glutaraldehyde/2% formaldehyde (EM-grade, Sigma
and Thermo Scientific) in PBS for 1 min at RT,
Cytofix/Cytoperm (BD Bioscience) for 5 min at 37°C,
2×5 min incubations in 50 mM NH4Cl/20 mM gly-
cine in PBS for 5 min at 37°C, 2×1X PBS washes,
20 min at RT with 200 ul of 1:40 Alexa Fluor 555-
conjugated phalloidin (Molecular Probes) in PBS, and
2×1X PBS washes. Coverslips were mounted with
ProLong Gold Mounting Medium (Molecular
Probes), and cured for 24 h at RT prior to imaging.
An aliquot of~4×10
6 reserved, unstimulated cells
was washed twice with cold PBS at 32 h post-
pHAGE transduction and ~5% of these cells were
FACS analyzed for ZsGreen expression, while the re-
mainder were lysed for western blotting and quanti-
tation of EXOC2 knockdown.
Confocal fluorescence microsopy
Slides of fixed cells prepared in triplicate as described
above were imaged using the 40X objective of a Zeiss
LSM 510 META scanning confocal microscope and Zeiss
LSM imaging software at the Harvard NeuroDiscovery
Center Optical Imaging Core Facility. ZsGreen-positive
cells were counted by using an ImageJ (NIH, v1.45p)
macro to analyze approximately 30 fields per sample at
40X magnification. The numbers of ZsGreen-positive
cells counted per sample were: 1441 cells for shEXOC2-
Nef, 2048 for shEXOC2 + Nef, 2997 for shControl-Nef,
and 1409 for shControl + Nef. The percentage of Nef-
expressing cells that formed nanotubes and nanotube-
like structures was calculated by manually counting the
number of connected cells and dividing the result by the
total number of ZsGreen-positive cells for a given sam-
ple. Percentages are reported as mean ± SEM.
Statistical analysis
Differences between pairs of groups were analyzed by
the Mann–Whitney U test. Differences were considered
significant at p≤0.05.
Additional files
Additional file 1: Table S1. Proteins detected via LC-MS/MS in
negative control, wild-type Nef, and mutant Nef samples. All proteins
detected via LC-MS/MS analysis of trichloroacetic acid-precipitated HA
immunocomplexes from FACS-sorted or unsorted Jurkat cells transduced
to express the denoted HA-tagged Nef or empty pHAGE vector are
shown alphabetically for side-by-side comparison. “Number of peptides”
indicates the number of distinct peptides from a single protein detected.
International Protein Index identification codes are provided in the “IPI”
column. Complete alphabetical listing of proteins detected via mass
spectrometry analysis for side-by-side comparision.
Additional file 2: Table S2. CompPASS statistical analysis of
proteins detected via LC-MS/MS in negative control, wild-type Nef,
and mutant Nef samples. All proteins detected via LC-MS/MS analysis of
trichloroacetic acid-precipitated HA immunocomplexes from FACS-sorted
or unsorted Jurkat cells transduced to express the denoted HA-tagged
Nef or empty pHAGE vector are shown, grouped sequentially by
descending D
N-score (defined in the text and in [55]). “TSC” column lists
the number of distinct peptides detected from a single protein. “Ratio”
denotes the proportion of mass spectrometry datasets in the CompPASS
database in which a given interactor was detected. Complete listing of
proteins detected via mass spectrometry analysis with CompPASS
statistics, listed sequentially by descending D
N-score.
Additional file 3: Figure S1. Statistical significance of protein
associations detected via LC-MS/MS analysis of wild-type 5C Nef
samples. Plotting D
N- versus Z-scores, as in [55], indicates that
Nef-association of select proteins detected exclusively in wild-type Nef
samples (red data points) is significant based on Z-score and/or D
N-score.
In a previous study conducted by the creators of CompPASS, Z≥4 and
D
N≥1 were used as significance thresholds [55]. In instances where D
N is
slightly less than 1, overwhelmingly high Z-scores compensate for the
D
N-score and indicate that statistical significance is likely. Plot of D
N
versus Z-scores for proteins detected via LC-MS/MS analysis of wild-type
5C-Nef samples.
Additional file 4: Table S3 Protein-protein relationship scores for
associations in STRING network. Scores assigned to protein-protein
association relationships in the STRING knowledgebase are shown for proteins
input into STRING to generate Figure 4B (described in the text). Confidence
scores for protein-protein associations in Figure 4B STRING network.
Additional file 5: Figure S2 Confocal image gallery of nanotubes,
nanotube-like structures, and filopodia in Jurkat cells expressing empty
pHAGE or pHAGE-Nef. Jurkat E6-1 cells transduced with vector virions
bearing pLKO.1- control shRNA followed by pHAGE-Nef-IRES-ZsGreen
or empty pHAGE, as described in Figure 5, were fixed and stained
with Alexa Fluor 555-conjugated phalloidin. Nanotubes, nanotube-like
structures, and filopodia were visualized via confocal microscopy;
selected zoomed images of these structures are shown. Scale bars,
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expressing Jurkat cells showing various phenotypes discussed in Figure 5.
Additional file 6: Figure S3 Comparison of proteins identified in
Nef proteomic and HIV RNAi screens. Datasets from Nef mass
spectrometry analyses conducted by Mukerji et al. in the present study
and Jager et al. (Krogan Lab) [17], together with results of RNAi screens
performed by Brass et al., Konig et al., Zhou et al., and Yeung et al.
[81,82,92,93] were input into Venny [94] to generate a Venn diagram
comparison. The Mukerji Nef dataset consists of 10 proteins identified
exclusively in 5C Nef immunocomplexes (Table 1). A minimum MiST score
threshold of 7.07×10
-9 was applied to the Jager et al. dataset of Nef-
interacting proteins in Jurkat cells (see Supplementary Data 3 in [17]).
Venn diagram comparison of Nef-interacting proteins identified by mass
spectrometry analysis of Nef immunocomplexes in the present study and
Jager et al., and molecules identified as important for HIV replication in
RNAi screens by Brass et al., Konig et al., Zhou et al., and Yeung et al.
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